Fatty Liver Isn't a Weight Problem
You Don't Have to Be Overweight to Have Fatty Liver
If you picture someone with fatty liver disease, you probably picture someone overweight. That assumption is wrong often enough that it has its own name in the research literature: lean NAFLD. In Asian population studies, it accounts for close to 40% of all fatty liver cases. Global prevalence sits at roughly 30% of adults, most of whom have no symptoms at all.
Body size was never actually the mechanism. It was just the easiest thing to notice from the outside.
What's Actually Happening
Fatty liver develops when the liver accumulates fat faster than it can process and clear it. In the majority of cases this isn't caused by alcohol; it's a metabolic processing failure. That processing failure can happen in a body carrying excess visceral fat, and it can happen just as easily in a body that looks lean, if the underlying metabolic machinery, insulin sensitivity, lipid processing, gut and liver function, isn't working the way it should. A normal BMI tells you very little about what's happening inside the liver itself.
This is also why the condition is often found by accident, on a blood panel or ultrasound ordered for something else entirely, in someone who would never have suspected it.
What TCM Was Already Tracking
Body shape is genuinely diagnostic information in TCM, assessed directly as part of Looking, one of the four diagnostic methods. A heavier build is read as a constitutional lean toward dampness, so that part of the Western assumption isn't wrong. It's just incomplete, because body size is one input among several, not the whole picture.
The pattern usually behind it explains why. A national expert consensus classifies fatty liver into TCM syndrome types, and independent clinical research consistently points to the same dominant pattern in most patients: Liver Qi Stagnation with Spleen Deficiency. The Spleen is responsible for transforming and transporting fluid through the body. When that function is impaired, fluid that should be processed and cleared accumulates instead, forming what TCM identifies as phlegm-damp. Constrained Liver Qi disrupts that transformation further, which is why the two show up together in most cases rather than as separate causes.
That impairment doesn't require a particular body size to occur. A lean person's Spleen function can fail in exactly the same way a heavier person's can, and the resulting phlegm-damp doesn't always surface as visible weight. This is why the four diagnostic methods are used together rather than relying on any one alone: tongue coating, pulse quality, and symptom pattern get read alongside body shape, so a lean presentation with the same underlying dysfunction doesn't get missed.
Why This Matters in Practice
The lean NAFLD research that opened this piece matters because it points to the same conclusion TCM's multi-input approach is built around: no single marker, body size included, tells the whole story. A normal weight doesn't rule out fatty liver, and a blood panel or scan doesn't replace the value of knowing how someone's Spleen and Liver are actually functioning day to day. Each catches something the other doesn't test for.
Neither replaces the other. They're looking at different things. A GP's blood work and imaging confirm what's happening at the tissue level. A TCM assessment adds the functional layer underneath it: how digestion and fluid processing are actually behaving, and what can be done about that alongside standard care. Borderline bloodwork, a scan that flagged early changes, or simply not fitting the picture you'd expect while something still feels off, any of these is a reasonable point to bring both approaches into the same conversation.
Get in touch via the contact form if you'd like to discuss your presentation.
References
Dai, X., Feng, J., Chen, Y., Huang, S., Shi, X., Liu, X., & Sun, Y. (2021). Traditional Chinese Medicine in nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives. Chinese Medicine, 16, 68. https://doi.org/10.1186/s13020-021-00469-4
Shi, T. T., Wu, L., Ma, W. J., Ju, L. P., Bai, M. H., Chen, X. W., et al. (2020). Nonalcoholic fatty liver disease: Pathogenesis and treatment in traditional Chinese medicine and Western medicine. Evidence-Based Complementary and Alternative Medicine, 2020, Article 8749564. https://doi.org/10.1155/2020/8749564
